Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabela Lens

Showing results (101-110 of 162) with videos related to

Pageof 17
Sort By:
Journal of Hepatology|September 8, 2025
The barriers to uptake of artificial intelligence in hepatology and how to overcome themJan Clusmann, Maria Balaguer-Montero, Octavi Bassegoda, et al.
The Journal of Clinical Investigation|November 29, 2021
SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodiesAnna Jeffery-Smith, Alice R Burton, Sabela Lens, et al.
Journal of Viral Hepatitis|August 25, 2018
Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antiviralsElena Perpiñán, Noelia Caro-Pérez, Neris García-González, et al.
Scientific Reports|May 21, 2026
Early hepatitis B and delta virus kinetics in patients undergoing liver transplantationSara Battistella, Anna Pocurull, Thais Leonel, et al.
Journal of Hepatology|December 5, 2020
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patientsMireia García-López, Sabela Lens, Laura J Pallett, et al.
Plos One|November 15, 2017
Evolution of acute hepatitis C virus infection in a large European city: Trends and new patternsCésar Garriga, Sandra Manzanares-Laya, Patricia García de Olalla, et al.
The Lancet. Infectious Diseases|August 19, 2017
Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trialXavier Forns, Samuel S Lee, Joaquin Valdes, et al.
Communications Medicine|December 14, 2023
Community-based screening enhances hepatitis B virus linkage to care among West African migrants in SpainCamila A Picchio, Daniel K Nomah, Ariadna Rando-Segura, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 9, 2021
Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological responseMattias Mandorfer, Fanny Turon, Sabela Lens, et al.
Alimentary Pharmacology & Therapeutics|April 21, 2026
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European StudyAdriana Palom, Elisabetta Degasperi, Barbara Coco, et al.
Pageof 17

Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
Journal of Hepatology|September 8, 2025
The barriers to uptake of artificial intelligence in hepatology and how to overcome themJan Clusmann, Maria Balaguer-Montero, Octavi Bassegoda, et al.
The Journal of Clinical Investigation|November 29, 2021
SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodiesAnna Jeffery-Smith, Alice R Burton, Sabela Lens, et al.
Journal of Viral Hepatitis|August 25, 2018
Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antiviralsElena Perpiñán, Noelia Caro-Pérez, Neris García-González, et al.
Scientific Reports|May 21, 2026
Early hepatitis B and delta virus kinetics in patients undergoing liver transplantationSara Battistella, Anna Pocurull, Thais Leonel, et al.
Journal of Hepatology|December 5, 2020
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patientsMireia García-López, Sabela Lens, Laura J Pallett, et al.
Plos One|November 15, 2017
Evolution of acute hepatitis C virus infection in a large European city: Trends and new patternsCésar Garriga, Sandra Manzanares-Laya, Patricia García de Olalla, et al.
The Lancet. Infectious Diseases|August 19, 2017
Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trialXavier Forns, Samuel S Lee, Joaquin Valdes, et al.
Communications Medicine|December 14, 2023
Community-based screening enhances hepatitis B virus linkage to care among West African migrants in SpainCamila A Picchio, Daniel K Nomah, Ariadna Rando-Segura, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 9, 2021
Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological responseMattias Mandorfer, Fanny Turon, Sabela Lens, et al.
Alimentary Pharmacology & Therapeutics|April 21, 2026
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European StudyAdriana Palom, Elisabetta Degasperi, Barbara Coco, et al.
Pageof 17